Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to $4.5 million.

  • Ironwood Pharmaceuticals' Interest & Investment Income fell 19.27% to $930,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 30.49%. This contributed to the annual value of $4.5 million for FY2024, which is 76.45% down from last year.
  • Ironwood Pharmaceuticals' Interest & Investment Income amounted to $4.5 million in FY2024, which was down 76.45% from $19.0 million recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Interest & Investment Income registered a high of $19.0 million during FY2023, and its lowest value of $726,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $11.0 million, with a median of $9.5 million in 2022.
  • As far as peak fluctuations go, Ironwood Pharmaceuticals' Interest & Investment Income spiked by 1,208.68% in 2022, and later tumbled by 76.45% in 2024.
  • Ironwood Pharmaceuticals' Interest & Investment Income (Yearly) stood at $1.5 million in 2020, then tumbled by 51.73% to $726,000 in 2021, then surged by 1,208.68% to $9.5 million in 2022, then spiked by 99.67% to $19.0 million in 2023, then tumbled by 76.45% to $4.5 million in 2024.